TrialAnnals of hematology2020

Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A.

Alexander Solms et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.